Respiratory News and Research

RSS

Managing tobacco smoking leads to reductions in opioid use, study shows

In a six-month study recently concluded, a research unit affiliated with two hospital institutions and a university in Ottawa found that a reduction in the number of cigarettes smoked daily also reduced a smoker's dependence on opioids.

25 Jan 2018

New study reveals an association between flu and heart attack

A new study has revealed a six-fold increased risk of heart attack during the first seven days of a laboratory-confirmed case of influenza.

25 Jan 2018

Researchers trace root cause of bronchiolitis symptoms

Every winter, doctors' offices and hospital emergency rooms fill with children who have bronchiolitis, an inflammation of the small airways in the lung.

25 Jan 2018

Researchers uncover molecular roots of genetic lung disease

Respiratory infections peak during the winter months, and most people recover within a few weeks. But for those with a rare genetic lung disease, the sniffling, coughing and congestion never end.

24 Jan 2018

Genome analysis reveals leprosy's origin and drug resistance

Leprosy is an infectious disease with gruesome symptoms. It damages the skin, peripheral nerves, the upper respiratory tract, and the eyes.

24 Jan 2018

Universal vaccine produces long-lasting immunity against influenza A viruses in mice

Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity in mice and protects them against the limitations of seasonal flu vaccines, according to a study led by Georgia State University.

24 Jan 2018

New report takes comprehensive look at health effects of e-cigarettes

A new congressionally mandated report from the National Academies of Sciences, Engineering, and Medicine takes a comprehensive look at evidence on the human health effects of e-cigarettes.

23 Jan 2018

New report reveals rapid growth in Vietnam pharmaceutical market

Vietnam healthcare market size, market segmentation by hospitals & clinics, diagnostic labs market, pharmaceutical market and medical devices market, The report also covers market in different aspects such as healthcare scenario in Vietnam, government and private spending on healthcare, cross comparison of healthcare sector of Vietnam with other Asia Pacific countries, mergers, acquisitions and funding in healthcare sector, investment model for setting up a hospital, snapshots of daycare centers and polyclinics, investment model for setting up a diagnostic laboratory, government regulations for launching a new drug, role of IT companies in Vietnam and comparative analysis of major players in each section.

23 Jan 2018

Researchers identify virus as likely cause of mystery polio-like paralysis

A major review by UNSW Sydney medical researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

22 Jan 2018

New bug may reduce misery of hay fever sufferers

A commonly-found weed that helps spread hay fever around Europe could be controlled by a new natural enemy.

22 Jan 2018

Study offers way to predict onset of lung disease in children with cystic fibrosis

Cystic fibrosis (CF) shortens life by making the lungs prone to repeated bacterial infections and associated inflammation.

19 Jan 2018

Older hospitalized patients less likely to be tested for influenza

This year's flu season is shaping up to be an especially serious one, and it's important for clinicians to promptly recognize, diagnosis, and treat influenza in hospitalized patients, especially in vulnerable populations such as older individuals.

19 Jan 2018

Expert discusses how to stay healthy during flu season

This year's influenza outbreak is already the most widespread on record since health officials began keeping track about a dozen years ago, with millions of Americans being infected by emerging and current strains such as the dominant H3N2.

18 Jan 2018

New biodegradable sensors could assist doctors when examining serious health conditions

This article features the recent development of biodegradable sensors which can be used to assist doctors when monitoring chronic health conditions.

17 Jan 2018

New biodegradable pressure sensor could help monitor serious health conditions

UConn engineers have created a biodegradable pressure sensor that could help doctors monitor chronic lung disease, swelling of the brain, and other medical conditions before dissolving harmlessly in a patient's body.

17 Jan 2018

New universal flu vaccine moves to clinical trial phase and could be a reality soon

Alphabet’s venture arm called Google Ventures earlier is one of the supporters of a mega projects that is developing a vaccine for flu that is safe and effective. Vaccitech from United Kingdom is working towards development of the vaccine and Alphabet has shown its support by contributing $27.6 million in new funding. The funds would be used conduct clinical trials and try the new vaccine.

16 Jan 2018

FDA grants approval for first drug to treat inherited breast cancer

The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation.

15 Jan 2018

Mitochondrial impairment may actually protect the brain in Parkinson's disease, study shows

A Norwegian study shows that impairment in mitochondria may actually protect the brain in Parkinson's disease.

15 Jan 2018

Past exposures influence immune response in children with acute respiratory tract infections

Acute respiratory tract infections (ARTI) are the leading global cause of death in early childhood, according to the Centers for Disease Control and Prevention.

12 Jan 2018

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.

12 Jan 2018